[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4855 followers Created: 2025-07-16 05:20:12 UTC #Akeso Announces First Patient Enrolled in the Phase III Trial AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer. $SMMT XXXXX engagements  **Related Topics** [$9926hk](/topic/$9926hk) [$smmt](/topic/$smmt) [Post Link](https://x.com/doepke_michel/status/1945352745789075532)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Michel Doepke @doepke_michel on x 4855 followers
Created: 2025-07-16 05:20:12 UTC
#Akeso Announces First Patient Enrolled in the Phase III Trial AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer. $SMMT
XXXXX engagements
/post/tweet::1945352745789075532